Market News
2 min read | Updated on July 02, 2024, 18:30 IST
SUMMARY
Nephro Care India IPO subscription window was open from June 28 to July 2. The share allotment status of the public issue is likely to be finalised by Wednesday, July 3. Nephro Care India shares are expected to be listed on the NSE SME platform on July 5.
Nephro Care India IPO subscribed nearly 716 times on last day: Check subscription, allotment status and listing
Nephro Care India IPO subscription closed with a huge demand. The public issue was booked over 700 times on the final day of bidding, Tuesday, July 2.
The initial public offer of Nephro Care India Ltd received bids for over 222.95 crore shares against 31,15,200 shares on offer for subscription, leading to an overall subscription of 715.7 times, the NSE data showed.
Demand for the NSE SME IPO was led by the Non-Institutional Investors (NIIs). The NIIs’ category received bids for over 110.68 crore shares compared to the 6.19 lakh shares set aside for the segment. The issue was booked 1,787.51 times in the NII category.
Retail investors placed bids for more than 91.57 crore shares against 14.44 lakh shares set aside for the portion, leading to a subscription of 633.8 times.
The Qualified Institutional Buyers (QIBs) applied for more than 20.23 crore shares compared to 8.25 lakh shares reserved for them. The QIBs’ segment was booked 245.13 times.
Nephro Care India IPO, worth ₹41.26 crore, is a book-building issue comprising an entirely fresh issue of 45.84 lakh shares. The price band for the issue was fixed at ₹85 to ₹90 per share.
The minimum lot size for retail investors for the Nephro Care India IPO was 1 lot consisting of 1,600 shares aggregating to a minimum investment of ₹1,44,000. The minimum lot size for High Net Worth Investors (HNIs) was 2 lots consisting of 3,200 shares, amounting to an application size of ₹2,88,000.
Nephro Care India IPO subscription window was open from June 28 to July 2. The share allotment status of the public issue is likely to be finalised by Wednesday, July 3. Refunds will be initiated for unsuccessful bidders and shares will be credited into the Demat accounts of successful bidders on July 4.
Nephro Care India shares are expected to be listed on the NSE SME platform on July 5.
Nephro Care India Limited was incorporated in 2014. Nephro Care India operates as a comprehensive treatment centre and offers a diverse range of clinical and lifestyle solutions. The hospital currently provides healthcare services to nearly 900 Chronic Kidney Disease patients every month.
About The Author
Next Story